Dear network, 🌟 It has been a while since I last shared updates, and I'm thrilled to bring you up to speed on all that has been happening and what is ahead! 🌟 Over the past six months, I have embarked on a journey across the USA, engaging with investors, industrial partners and most importantly, users. Reflecting on my time in Silicon Valley, I have gained valuable insights into the challenges of fundraising in today's landscape. While the allure of seed-stage investment remains strong, I have observed a shift where investors increasingly seek near-series A achievements. Even as a deeptech startup, I have encountered expectations for user traction and revenue before advancing discussions. In response to this feedback, I am happy to announce that we have launched the beta-testing phase of our Orusight platform across the USA, collaborating closely with optometrists and patients to iterate and enhance our service based on their invaluable feedback. 🚀 Furthermore, I am proud to announce that RetiNov has evolved into a multinational entity, following the incorporation of our US branch. 🇺🇸 Also, I would like to extend my gratitude to Bpifrance and Les Deeptech 🚀 for featuring #Retinov in the insightful article below, which encapsulates our journey and our mission to promote healthy aging by providing healthcare professionals and their patients with predictive, actionable, and targeted solutions. Last but not least, starting next month, I commit to sharing regular updates on Retinov's progress via email every first day of the month! If you are interested, please feel free to DM me your email address, and I will ensure you are included in our mailing list. Thank you for your continued support, and here is to the exciting journey ahead! 🥂 #startup #healthcare #medicaltechnology #entrepreneurship #innovation #siliconvalley
🚀 Découvrez l’Épopée de RetiNov : Une Startup Propulsée par les services Tandem & Tango ! Laissez-vous inspirer par l’expérience de RetiNov, une startup qui joue un rôle essentiel dans la prévention de la DMLA (dégénérescence maculaire liée à l’âge). RetiNov, accompagnée d'Aquitaine Science Transfert (SATT Aquitaine) a été lauréate du concours i-PhD. Elle propose une technologie de rupture dans le domaine de la santé. 👓🌟 👉 https://lnkd.in/emEd4pk8 Soufiane Ajana, PhD Jean Le Pavec Thibaud Lefèvre Tatiana Cohen de Lara Cecile Delcourt Stephane Wolf Howard Purcell Baris Ersezer Laurent Lévy Marie-Laure Saillard Jean Carrier #deeptech #startup #entreprenariat #santé #medtech
Jihad Sinnate
7mo
Gold Luck, you deserve the best Soufiane Ajana, PhD 🫡
Amazing Soufiane Ajana, PhD, to the moon!🚀
Excellent work
Spécialiste Performance et Qualité Conditionnement chez CEVA SANTE ANIMALE
7moCongrat Soufiane Ajana, PhD, the travel is on going for RetiNov. All the best